View:
Download DOC
Download PDF
Download XLS

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Vesper Healthcare Acquisition Corp.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   85-1908962

(State of Incorporation

or Organization)

  

(I.R.S. Employer

Identification No.)

   

1819 West Avenue

Bay 2

Miami Beach, Florida

  33139
(Address of Principal Executive Offices)   (Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

to be Registered

  

Name of Each Exchange on Which

Each Class is to be Registered

   
Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant   The Nasdaq Stock Market LLC
   
Class A Common Stock, par value $0.0001 per share   The Nasdaq Stock Market LLC
   
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50   The Nasdaq Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box.  ☒

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box.  ☐

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

 

Securities Act Registration Statement or Regulation A offering statement file number to which this form

relates: 333-248717 (if applicable)

 

Securities to be registered pursuant to Section 12(g) of the Act:

N/A

(Title of Class)

 

 

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

 

The securities to be registered hereby are the units, Class A common stock and warrants to purchase shares of Class A common stock of Vesper Healthcare Acquisition Corp. (the “Company”). The description of the units, Class A common stock and warrants contained in the section entitled “Description of Securities” in the prospectus included in the Company’s Registration Statement on Form S-1 (File No. 333-248717) filed with the U.S. Securities and Exchange Commission on September 10, 2020, as amended from time to time (the “Registration Statement”), to which this Form 8-A relates, is incorporated herein by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that is subsequently filed is also incorporated by reference herein.

 

Item 2. Exhibits.

 

The following exhibits have been filed as exhibits to the Registration Statement, as amended, and are incorporated herein by reference:

 

Exhibit No.

  

Description

3.1   Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 (File No. 333-248717), filed with the Securities and Exchange Commission on September 10, 2020).
     
3.2   Form of Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1/A (File No. 333-248717), filed with the Securities and Exchange Commission on September 21, 2020).
   
3.3   By Laws (incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 (File No. 333-248717), filed with the Securities and Exchange Commission on September 10, 2020).
   
4.1   Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-1/A (File No. 333-248717), filed with the Securities and Exchange Commission on September 21, 2020).
   
4.2   Specimen Class A Common Stock Certificate (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1/A (File No. 333-248717), filed with the Securities and Exchange Commission on September 21, 2020).
   
4.3   Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-1/A (File No. 333-248717), filed with the Securities and Exchange Commission on September 21, 2020).
   
4.4   Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-1/A (File No. 333-248717), filed with the Securities and Exchange Commission on September 21, 2020).
   
10.1   Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form S-1/A (File No. 333-248717), filed with the Securities and Exchange Commission on September 21, 2020).
   
10.2   Form of Registration Rights Agreement between the Company and certain security holders (incorporated by reference to Exhibit 10.2 to the Company’s Registration Statement on Form S-1/A (File No. 333-248717), filed with the Securities and Exchange Commission on September 21, 2020).

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

  VESPER HEALTHCARE ACQUISITION CORP.
   
  By: /s/ Brenton L. Saunders
    Brenton L. Saunders
    Chief Executive Officer

Dated: September 25, 2020

 

 

2